Literature DB >> 22425083

Effect of central obesity on prostate specific antigen measured by computerized tomography: related markers and prostate volume.

Seung-Guk Park1, Ho-Chun Choi, Belong Cho, Young-Min Kwon, Hyuk-Tae Kwon, Jin-Ho Park.   

Abstract

PURPOSE: We assessed the effects of central adiposity represented by visceral adipose tissue on prostate volume, prostate specific antigen, and prostate specific antigen mass and mass ratio.
MATERIALS AND METHODS: This cross-sectional study included 6,389 Asian men 30 to 79 years old. Prostate volume was estimated by transrectal ultrasound. Visceral and subcutaneous adipose tissue was measured by computerized tomography. Multivariate linear regression analysis was done between prostate specific antigen related variables and obesity indexes such as body mass index, waist circumference, and visceral and subcutaneous adipose tissue after adjusting for age.
RESULTS: Body mass index, waist circumference and subcutaneous adipose tissue were inversely associated with prostate specific antigen (p for trend <0.001) but visceral adipose tissue showed no associations with prostate specific antigen (p for trend = 0.740). Waist circumference, and visceral and subcutaneous adipose tissue were positively associated with prostate specific antigen mass (p for trend = 0.014, <0.001 and 0.036, respectively). However, body mass index did not show this association (p for trend = 0.372). Body mass index, waist circumference and subcutaneous adipose tissue negatively affected the prostate specific antigen mass ratio (each p for trend <0.05) but there was no such significant correlation for visceral adipose tissue (p for trend = 0.187). When adjusted for visceral adipose tissue body mass index was not associated with prostate volume (p for trend = 0.152) but visceral adipose tissue remained positively associated with prostate volume even after adjusting for body mass index (p for trend = 0.005).
CONCLUSIONS: Visceral adiposity is the main determining factor of the prostate volume increase and prostate specific antigen production.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425083     DOI: 10.1016/j.juro.2011.12.067

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Challenging the Inevitability of Prostate Enlargement: Low Levels of Benign Prostatic Hyperplasia Among Tsimane Forager-Horticulturalists.

Authors:  Benjamin C Trumble; Jonathan Stieglitz; Daniel Eid Rodriguez; Edhitt Cortez Linares; Hillard S Kaplan; Michael D Gurven
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-04-28       Impact factor: 6.053

Review 2.  Association between body mass index and urinary tract infection: a systematic review and meta-analysis of observational cohort studies.

Authors:  Habeeb Alhabeeb; Saeed Baradwan; Hamed Kord-Varkaneh; Shing Cheng Tan; Teck Yew Low; Osama Alomar; Hany Salem; Ismail Abdulrahman Al-Badawi; Ahmed Abu-Zaid
Journal:  Eat Weight Disord       Date:  2021-01-09       Impact factor: 4.652

3.  Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levels.

Authors:  Keisuke Goto; Hirotaka Nagamatsu; Jun Teishima; Yuki Kohada; Shinsuke Fujii; Yoshimasa Kurimura; Koji Mita; Masanobu Shigeta; Satoshi Maruyama; Yoji Inoue; Mitsuru Nakahara; Akio Matsubara
Journal:  Mol Clin Oncol       Date:  2017-04-10

4.  Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen.

Authors:  Sean Harrison; Kate Tilling; Emma L Turner; Richard M Martin; Rosie Lennon; J Athene Lane; Jenny L Donovan; Freddie C Hamdy; David E Neal; J L H Ruud Bosch; Hayley E Jones
Journal:  Cancer Causes Control       Date:  2020-03-11       Impact factor: 2.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.